Our skin health and care management tool provides reliable early assessment, and care management of dermatological and vascular conditions like bedsores.
We empower caregivers to prevent deadly wounds with a low cost skin health assessment and care management tool. Our initial target is deadly bedsores. We addresses this $26 billion healthcare problem by providing a low cost reliable early detection system. A low risk FDA pathway allows a quick path to a $4.2 billion US market. Two recurring revenues from a razor-blade and SaaS model supports growth to $240M within 6 years of product launch.